{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:39:58Z","timestamp":1784637598557,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2025-77"],"award-info":[{"award-number":["ORF-2025-77"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23431-y","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:23:45Z","timestamp":1760541825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of novel DYRK1A inhibitors as treatment options for alzheimer\u2019s disease through comprehensive in silico approaches"],"prefix":"10.1038","volume":"15","author":[{"given":"Ibrahim Akindeji","family":"Makinde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheriffdeen Oladimeji","family":"Hammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najwa Ahmad","family":"Kuthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna Isiyaku","family":"Umar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temitayo Abidat","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idayat Oyinkansola","family":"Kehinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridwan Opeyemi","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi Tunde","family":"Aborode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajudeen Ogundare","family":"Jimoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Djazouli O.","family":"Mahamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Almohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"23(11)","key":"23431_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.31083\/j.jin2311197","volume":"30","author":"F Zhou","year":"2024","unstructured":"Zhou, F., Zhao, Y., Sun, Y. & Chen, W. Molecular insights into Tau pathology and its therapeutic strategies in alzheimer\u2019s disease. J. Integr. Neurosci. 30 (23(11)), 197. https:\/\/doi.org\/doi (2024).","journal-title":"J. Integr. Neurosci."},{"key":"23431_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01911-3","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Recent advances in alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal. Transduct. Target. Ther. https:\/\/doi.org\/10.1038\/s41392-024-01911-3 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"23431_CR3","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.57078","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Interaction between A\u03b2 and Tau in the pathogenesis of alzheimer\u2019s disease. Int. J. Biol. Sci. https:\/\/doi.org\/10.7150\/ijbs.57078 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"23431_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2020.04.020","author":"H Yu","year":"2020","unstructured":"Yu, H. & Dalby, P. A. A beginner\u2019s guide to molecular dynamics simulations and the identification of cross-correlation networks for enzyme engineering. Methods Enzymol. CD-ROM\/Methods Enzymol. https:\/\/doi.org\/10.1016\/bs.mie.2020.04.020 (2020).","journal-title":"Methods Enzymol. CD-ROM\/Methods Enzymol."},{"issue":"7","key":"23431_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4103\/1673-5374.385847","volume":"1","author":"J Ye","year":"2024","unstructured":"Ye, J., Wan, H., Chen, S. & Liu, G. P. Targeting Tau in alzheimer\u2019s disease: from mechanisms to clinical therapy. Neural Regen Res. 1 (7), 1489\u20131498. https:\/\/doi.org\/10.4103\/1673-5374.385847 (2024).","journal-title":"Neural Regen Res."},{"issue":"2","key":"23431_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","volume":"Jan;278","author":"J Wegiel","year":"2011","unstructured":"Wegiel, J., Gong, C. X. & Hwang, Y. W. The role of DYRK1A in neurodegenerative diseases. FEBS J. Jan;278 (2), 236\u2013. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07955.x (2011). 45.","journal-title":"FEBS J."},{"key":"23431_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2017.00087","author":"C Wang","year":"2018","unstructured":"Wang, C., Greene, D., Xiao, L., Qi, R. & Luo, R. Recent developments and applications of the MMPBSA method. Front. Mol. Biosci. https:\/\/doi.org\/10.3389\/fmolb.2017.00087 (2018).","journal-title":"Front. Mol. Biosci."},{"key":"23431_CR8","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S. et al. A new tool to perform End-State free energy calculations with GROMACS. J. Chem. Theory Comput. 17, 6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"23431_CR9","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","volume":"16","author":"T Tuccinardi","year":"2021","unstructured":"Tuccinardi, T. What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery? Expert Opin. Drug Discov. 16, 1233\u20131237. https:\/\/doi.org\/10.1080\/17460441.2021.1942836 (2021).","journal-title":"Expert Opin. Drug Discov."},{"key":"23431_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Tropsha","year":"2010","unstructured":"Tropsha, A. Best practices for QSAR model development, validation, and exploitation. Mol. Inf. 29, 476\u2013488. https:\/\/doi.org\/10.1002\/minf.201000061 (2010).","journal-title":"Mol. Inf."},{"key":"23431_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-022-05373-8","volume":"28","author":"H Tian","year":"2022","unstructured":"Tian, H., Ketkar, R., Tao, P. & ADMETboost A web server for accurate ADMET prediction. -Journal Mol. Model. 28, 1\u20136 (2022).","journal-title":"-Journal Mol. Model."},{"key":"23431_CR12","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1021\/acs.jcim.9b00432","volume":"59","author":"B Thapa","year":"2019","unstructured":"Thapa, B. & Raghavachari, K. Energy decomposition analysis of Protein\u2009\u2013\u2009Ligand interactions using Molecules-in-Molecules Fragmentation-Based method [Research-article. J. Chem. Inf. Model. 59, 3474\u20133484. https:\/\/doi.org\/10.1021\/acs.jcim.9b00432 (2019).","journal-title":"J. Chem. Inf. Model."},{"key":"23431_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.15406\/japlr.2018.07.00230","volume":"9","author":"AK Thakur","year":"2018","unstructured":"Thakur, A. K., Kamboj, P. & Goswami, K. Pathophysiology and management of alzheimer\u2019s disease: an overview. J. Anal. Pharm. Res. 9, 226\u2013235. https:\/\/doi.org\/10.15406\/japlr.2018.07.00230 (2018).","journal-title":"J. Anal. Pharm. Res."},{"key":"23431_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2174\/0929867329666220620162018","volume":"30","author":"MM Souza","year":"2023","unstructured":"Souza, M. M. et al. DYRK1A inhibitors and perspectives for the treatment of alzheimer\u2019s disease. Curr. Med. Chem. 30, 669\u2013688. https:\/\/doi.org\/10.2174\/0929867329666220620162018 (2023).","journal-title":"Curr. Med. Chem."},{"key":"23431_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.str.2013.03.012","volume":"21","author":"M Soundararajan","year":"2013","unstructured":"Soundararajan, M. et al. Structures of down syndrome kinases. DYRKs, reveal mechanisms of kinase activation and substrate. Recognit. Struct. 21, 986\u2013996. https:\/\/doi.org\/10.1016\/j.str.2013.03.012 (2013).","journal-title":"Recognit. Struct."},{"key":"23431_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49858-x","author":"X Song","year":"2024","unstructured":"Song, X. et al. Accurate prediction of protein structural flexibility by deep learning integrating intricate atomic structures and Cryo-EM density information. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-024-49858-x (2024).","journal-title":"Nat. Commun."},{"key":"23431_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.12688\/f1000research.145391.3","volume":"13","author":"SR Shri","year":"2025","unstructured":"Shri, S. R., Nayak, Y. & Pai, S. R. Molecular Docking studies and molecular dynamic simulation analysis: to identify novel ATP-competitive Inhibition of glycogen synthase kinase-3\u03b2 for alzheimer\u2019s disease. F1000Research 13, 773. https:\/\/doi.org\/10.12688\/f1000research.145391.3 (2025).","journal-title":"F1000Research"},{"key":"23431_CR18","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/molecules27041159","volume":"27","author":"MM Shahroz","year":"2022","unstructured":"Shahroz, M. M. et al. Novel and potential small molecule scaffolds as DYRK1A inhibitors by integrated molecular Docking-Based virtual screening and dynamics simulation study. Molecules 27, 1159. https:\/\/doi.org\/10.3390\/molecules27041159 (2022).","journal-title":"Molecules"},{"issue":"10284","key":"23431_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"24","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 24 (10284), 1577\u20131590 (2021). 10 1016 0140\u20136736 20 32205-4.","journal-title":"Lancet"},{"key":"23431_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202204231","author":"KS Sandhya","year":"2023","unstructured":"Sandhya, K. S., Arunkumar, B., Shiny, L. P. & Achuthsankar, S. N. Molecular dynamics and free energy landscape study of SARS-CoV\u20102 omicron mpro boswellic acid compounds of Boswellia serrata inhibitors. Chem. Select. https:\/\/doi.org\/10.1002\/slct.202204231 (2023).","journal-title":"Chem. Select."},{"issue":"8","key":"23431_CR21","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4103\/1673-5374.332127","volume":"Aug;17","author":"AR Roda","year":"2022","unstructured":"Roda, A. R., Serra-Mir, G., Montoliu-Gaya, L., Tiessler, L. & Villegas, S. Amyloid-beta peptide and Tau protein crosstalk in alzheimer\u2019s disease. Neural Regen Res. Aug;17 (8), 1666\u20131674. https:\/\/doi.org\/10.4103\/1673-5374.332127 (2022).","journal-title":"Neural Regen Res."},{"key":"23431_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841","author":"P Rawat","year":"2022","unstructured":"Rawat, P. et al. Phosphorylated Tau in alzheimer\u2019s disease and other tauopathies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232112841 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"23431_CR23","doi-asserted-by":"publisher","first-page":"132024","DOI":"10.1016\/j.ijbiomac.2024.132024","volume":"269","author":"N Qiu","year":"2024","unstructured":"Qiu, N. et al. Discovery of a novel chemotype as DYRK1A inhibitors against alzheimer\u2019s disease: computational modeling and biological evaluation. Int. J. Biol. Macromol. 269, 132024. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132024 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"23431_CR24","doi-asserted-by":"publisher","first-page":"18114","DOI":"10.1038\/s41598-023-44810-3","volume":"13","author":"K Pustelny","year":"2023","unstructured":"Pustelny, K. et al. Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics. Sci. Rep. 13, 18114. https:\/\/doi.org\/10.1038\/s41598-023-44810-3 (2023).","journal-title":"Sci. Rep."},{"key":"23431_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.crstbi.2022.04.002","volume":"4","author":"VM Prabantu","year":"2022","unstructured":"Prabantu, V. M., Gadiyaram, V., Vishveshwara, S. & Srinivasan, N. Understanding structural variability in proteins using protein structural networks. Curr. Res. Struct. Biology. 4, 134\u2013145. https:\/\/doi.org\/10.1016\/j.crstbi.2022.04.002 (2022).","journal-title":"Curr. Res. Struct. Biology"},{"key":"23431_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cphc.202200491","author":"J Palma","year":"2022","unstructured":"Palma, J. & Pierdominici-Sottile, G. On the uses of PCA to characterise molecular dynamics simulations of biological macromolecules: Basics and tips for an effective use. Chem. Phys. Chem. https:\/\/doi.org\/10.1002\/cphc.202200491 (2022).","journal-title":"Chem. Phys. Chem."},{"key":"23431_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.05.565671","author":"C Okamoto","year":"2023","unstructured":"Okamoto, C. & Ando, K. Molecular dynamics simulation analysis of structural dynamic cross-correlation induced by odorant hydrogen-bonding in mouse eugenol olfactory receptor. bioRxiv. Cold Spring Harb. Lab. https:\/\/doi.org\/10.1101\/2023.11.05.565671 (2023).","journal-title":"Cold Spring Harb. Lab."},{"key":"23431_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1090","author":"Y Ogawa","year":"2010","unstructured":"Ogawa, Y. et al. Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A. Nat. Commun. https:\/\/doi.org\/10.1038\/ncomms1090 (2010).","journal-title":"Nat. Commun."},{"key":"23431_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1704143114","author":"A Nakano-Kobayashi","year":"2017","unstructured":"Nakano-Kobayashi, A. et al. Prenatal neurogenesis induction therapy normalizes brain structure and function in down syndrome mice. Proc. Natl. Acad. Sci. USA A. https:\/\/doi.org\/10.1073\/pnas.1704143114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA A"},{"key":"23431_CR30","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.euroneuro.2015.03.018","volume":"25","author":"G Naert","year":"2015","unstructured":"Naert, G. et al. Leucettine L41, a DYRK1A-preferential DYRKs\/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric A\u03b225\u201335 peptide administration in mice. Eur. Neuropsychopharmacology: J. Eur. Coll. Neuropsychopharmacol. 25, 2170\u20132182. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.03.018 (2015).","journal-title":"Eur. Neuropsychopharmacology: J. Eur. Coll. Neuropsychopharmacol."},{"key":"23431_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201707641","author":"BS Morgan","year":"2017","unstructured":"Morgan, B. S., Forte, J. E., Culver, R. N., Zhang, Y. & Hargrove, A. E. Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA. Angewandte Chem. Inter. Ed. https:\/\/doi.org\/10.1002\/anie.201707641 (2017).","journal-title":"Angewandte Chem. Inter. Ed."},{"key":"23431_CR32","author":"S Moradi","year":"2024","unstructured":"Moradi, S. et al. A review on description dynamics and conformational changes of proteins using a combination of principal component analysis and molecular dynamics simulation. Comput. Biol. Med. ;183, 109245. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109245,\u00a0(2024)."},{"key":"23431_CR33","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s42250-022-00411-7","volume":"5","author":"JO Mensah","year":"2022","unstructured":"Mensah, J. O. et al. Allosteric modulation of the main protease (MPro) of SARS-CoV-2 by casticin\u2014Insights from molecular dynamics simulations. Chem. Afr. 5, 1305\u20131320. https:\/\/doi.org\/10.1007\/s42250-022-00411-7 (2022).","journal-title":"Chem. Afr."},{"key":"23431_CR34","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.18632\/aging.202703","volume":"13","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CLpro through high-throughput virtual screening and molecular dynamics simulation. Aging 13, 6258\u20136272. https:\/\/doi.org\/10.18632\/aging.202703 (2021).","journal-title":"Aging"},{"issue":"1\u20133","key":"23431_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv Rev. 46 (1\u20133), 3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0 (2001).","journal-title":"Adv. Drug Deliv Rev."},{"key":"23431_CR36","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c02068","author":"MF Lindberg","year":"2023","unstructured":"Lindberg, M. F. et al. Comparative efficacy and selectivity of Pharmacological inhibitors of DYRK and CLK protein kinases. J. Med. Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c02068 (2023).","journal-title":"J. Med. Chem."},{"key":"23431_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.14283\/jpad.2023.43","volume":"10","author":"SCB Leonardo Iaccarino","year":"2023","unstructured":"Leonardo Iaccarino, S. C. B. & Dowsett, S. A. Diagnostic biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease. an overview of tests for clinical practice in the United States and Europe. J. Prev. Alzheimer\u2019s Dis. 10, 426 (2023).","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"23431_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-3135-4","author":"S Kwon","year":"2019","unstructured":"Kwon, S., Bae, H., Jo, J. & Yoon, S. Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-019-3135-4 (2019).","journal-title":"BMC Bioinform."},{"key":"23431_CR39","doi-asserted-by":"publisher","first-page":"13497","DOI":"10.1080\/07391102.2021.1989040","volume":"40","author":"M Kumari","year":"2021","unstructured":"Kumari, M., Singh, R. & Subbarao, N. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of Mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation. J. Biomol. Struct. Dynamics. 40, 13497\u201313526. https:\/\/doi.org\/10.1080\/07391102.2021.1989040 (2021).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"23431_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1017\/jfm.2011.18","volume":"675","author":"A Kumar","year":"2011","unstructured":"Kumar, A. & Higdon, J. J. L. Particle mesh Ewald Stokesian dynamics simulations for suspensions of non-spherical particles. J. Fluid Mech. 675, 297\u2013335. https:\/\/doi.org\/10.1017\/jfm.2011.18 (2011).","journal-title":"J. Fluid Mech."},{"key":"23431_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091576","author":"S Kothiwale","year":"2017","unstructured":"Kothiwale, S., Borza, C., Pozzi, A. & Meiler, J. Quantitative structure\u2013activity relationship modeling of kinase selectivity profiles. Molecules: J. Synth. Chem. Nat. Prod. Chem. https:\/\/doi.org\/10.3390\/molecules22091576 (2017).","journal-title":"Molecules: J. Synth. Chem. Nat. Prod. Chem."},{"issue":"1","key":"23431_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"13","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers. 13 (1), 33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"23431_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphi.2025.100824","author":"D Karthikeyan","year":"2025","unstructured":"Karthikeyan, D., Kumar, S. & Jayaprakash, N. Pharmacophore-based approach for the identification of prospective UDP-2,3-diacylglucosamine hydrolase (LpxH) inhibitor from natural product database against Salmonella typhi. Chem. Phys. Impact https:\/\/doi.org\/10.1016\/j.chphi.2025.100824 (2025).","journal-title":"Chem. Phys. Impact"},{"issue":"1","key":"23431_CR44","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1038\/s41467-021-26935-z","volume":"16","author":"IH Kaltheuner","year":"2021","unstructured":"Kaltheuner, I. H. et al. Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. Nat. Commun. 16 (1), 6607. https:\/\/doi.org\/10.1038\/s41467-021-26935-z (2021).","journal-title":"Nat. Commun."},{"key":"23431_CR45","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1039\/c9nr10638c","volume":"12","author":"K Huang","year":"2020","unstructured":"Huang, K. et al. An accurate free energy estimator: based on MM\/PBSA combined with interaction entropy for protein\u2013ligand binding affinity. Nanoscale 12, 10737\u201310750. https:\/\/doi.org\/10.1039\/c9nr10638c (2020).","journal-title":"Nanoscale"},{"key":"23431_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1021\/ci100059q","volume":"50","author":"Y Hu","year":"2010","unstructured":"Hu, Y. & Bajorath, J. Molecular scaffolds with high propensity to form multi-target activity cliffs. J. Chem. Inf. Model. 50, 500\u2013510. https:\/\/doi.org\/10.1021\/ci100059q (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"23431_CR47","first-page":"37","volume":"8","author":"A Hospital","year":"2015","unstructured":"Hospital, A., Goni, J. R., Orozco, M. & Gelgi, J. Molecular dynamics simulations: advances and applications. Adv. Application Bioinfomatics Chem. 8, 37\u201347 (2015). https:\/\/doaj.org\/article\/901fd7fe2a8145d880f02eb3e58dcf2d","journal-title":"Adv. Application Bioinfomatics Chem."},{"key":"23431_CR48","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/physreva.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover, W. G. Canonical dynamics: equilibrium phase-space distributions. Phys. Rev. Gen. Phys. 31, 1695\u20131697. https:\/\/doi.org\/10.1103\/physreva.31.1695 (1985).","journal-title":"Phys. Rev. Gen. Phys."},{"key":"23431_CR49","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth, S. A. & Dror, R. O. Molecular dynamics simulation for all. Neuron 99, 1129\u20131143. https:\/\/doi.org\/10.1016\/j.neuron.2018.08.011 (2018).","journal-title":"Neuron"},{"key":"23431_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E. et al. OPLS3: A force field providing broad coverage of Drug-like small molecules and proteins. J. Chem. Theory Comput. 12, 281\u2013296 (2016).","journal-title":"J. Chem. Theory Comput."},{"issue":"12","key":"23431_CR51","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1242\/dev.066167","volume":"138","author":"B H\u00e4mmerle","year":"2011","unstructured":"H\u00e4mmerle, B. et al. Transient expression of Mnb\/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development 138(12), 2543\u20132554 (2011).","journal-title":"Development"},{"key":"23431_CR52","doi-asserted-by":"publisher","DOI":"10.2174\/0115701808306787240709073814","author":"A Guendouze","year":"2024","unstructured":"Guendouze, A., Mokrani, E. H., Benslama, O. & Lekmine, S. Virtual screening and molecular dynamics of avenanthramides as potential \u03b1-glucosidase inhibitors. Lett. Drug Des. Discovery https:\/\/doi.org\/10.2174\/0115701808306787240709073814 (2024).","journal-title":"Lett. Drug Des. Discovery"},{"key":"23431_CR53","first-page":"4","volume":"14","author":"H Grimberg","year":"2022","unstructured":"Grimberg, H. et al. Machine learning approaches to optimize small-molecule inhibitors for RNA targeting. J. Chem. 14, 4 (2022).","journal-title":"J. Chem."},{"key":"23431_CR54","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"23431_CR55","doi-asserted-by":"publisher","DOI":"10.1063\/5.0098269","author":"Y Fang","year":"2022","unstructured":"Fang, Y. et al. Efficient exploration of complex free energy landscapes by stepwise multi-subphase space metadynamics. J. Chem. Phys. https:\/\/doi.org\/10.1063\/5.0098269 (2022).","journal-title":"J. Chem. Phys."},{"key":"23431_CR56","doi-asserted-by":"publisher","DOI":"10.1039\/d0cs01261k","author":"JP Falese","year":"2021","unstructured":"Falese, J. P., Donlic, A. & Hargrove, A. E. Targeting RNA with small molecules: from fundamental principles towards the clinic. Chem. Soc. Rev. https:\/\/doi.org\/10.1039\/d0cs01261k (2021).","journal-title":"Chem. Soc. Rev."},{"key":"23431_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa223","author":"E Drummond","year":"2020","unstructured":"Drummond, E. et al. Phosphorylated Tau interactome in the human alzheimer\u2019s disease brain. Brain https:\/\/doi.org\/10.1093\/brain\/awaa223 (2020).","journal-title":"Brain"},{"key":"23431_CR58","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/iub.2282","volume":"72","author":"ZS Derewenda","year":"2020","unstructured":"Derewenda, Z. S., Hawro, I. & Derewenda, U. CH\u22efO hydrogen bonds in kinase-inhibitor interfaces. IUBMB Life. 72, 1233\u20131242. https:\/\/doi.org\/10.1002\/iub.2282 (2020).","journal-title":"IUBMB Life"},{"issue":"9","key":"23431_CR59","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1038\/s41380-020-00997-9","volume":"Sep;26","author":"S Delhaye","year":"2021","unstructured":"Delhaye, S. & Bardoni, B. Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders. Mol. Psychiatry. Sep;26 (9), 4570\u20134582. https:\/\/doi.org\/10.1038\/s41380-020-00997-9 (2021).","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"23431_CR60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jnc.13018","volume":"May;133","author":"S Coutadeur","year":"2015","unstructured":"Coutadeur, S. et al. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of alzheimer\u2019s disease: effect on Tau and amyloid pathologies in vitro. J. Neurochem. May;133 (3), 440\u2013451. https:\/\/doi.org\/10.1111\/jnc.13018 (2015).","journal-title":"J. Neurochem"},{"key":"23431_CR61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-802395-2.00023-7","volume":"145","author":"AL Calderon-Garcidue\u00f1as","year":"2017","unstructured":"Calderon-Garcidue\u00f1as, A. L. & Duyckaerts, C. Alzheimer disease. Handb. Clin. Neurol. 145, 325\u2013337. https:\/\/doi.org\/10.1016\/B978-0-12-802395-2.00023-7 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"23431_CR62","doi-asserted-by":"publisher","first-page":"110238","DOI":"10.1016\/j.jcp.2021.110238","volume":"435","author":"PL Barclay","year":"2021","unstructured":"Barclay, P. L. & Zhang, D. Z. Periodic boundary conditions for arbitrary deformations in molecular dynamics simulations. J. Comput. Phys. 435, 110238. https:\/\/doi.org\/10.1016\/j.jcp.2021.110238 (2021).","journal-title":"J. Comput. Phys."},{"key":"23431_CR63","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.sjbs.2023.103753","volume":"30","author":"ZK Bagewadi","year":"2023","unstructured":"Bagewadi, Z. K. et al. Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of micrococcus luteus with secondary metabolites from Bacillus licheniformis recognized by genome mining approach. Saudi J. Biol. Sci. 30, 103753. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103753 (2023).","journal-title":"Saudi J. Biol. Sci."},{"key":"23431_CR64","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.3390\/molecules27134098","volume":"27","author":"M Aziz","year":"2022","unstructured":"Aziz, M. et al. Deep learning and structure-based virtual screening for drug discovery against NEK7: A novel target for the treatment of cancer. Molecules 27, 4098. https:\/\/doi.org\/10.3390\/molecules27134098 (2022).","journal-title":"Molecules"},{"key":"23431_CR65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/oxygen1020010","volume":"1","author":"A Atlante","year":"2021","unstructured":"Atlante, A., Valenti, D., Latina, V. & Amadoro, G. Role of Oxygen Radicals in Alzheimer\u2019s Disease: Focus on tau protein 2021. Oxygen 1, 96\u2013120. https:\/\/doi.org\/10.3390\/oxygen1020010 (2021).","journal-title":"Oxygen"},{"key":"23431_CR66","doi-asserted-by":"publisher","first-page":"105660","DOI":"10.1016\/j.cmpb.2020.105660","volume":"195","author":"K Al-Khafaji","year":"2020","unstructured":"Al-Khafaji, K. & Tok, T. T. Molecular dynamics simulation, free energy landscape, and binding free energy computations in exploring the anti-invasive activity of amygdalin against metastasis. Comput. Methods Programs Biomed. 195, 105660. https:\/\/doi.org\/10.1016\/j.cmpb.2020.105660 (2020).","journal-title":"Comput. Methods Programs Biomed."},{"key":"23431_CR67","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.abb.2010.12.024","volume":"507","author":"T Adayev","year":"2010","unstructured":"Adayev, T., Wegiel, J. & Hwang, Y-W. Harmine is an ATP-competitive inhibitor for Dual-Specificity tyrosine Phosphorylation-Regulated kinase 1A (Dyrk1A. Arch. Biochem. Biophys. 507, 212. https:\/\/doi.org\/10.1016\/j.abb.2010.12.024 (2010).","journal-title":"Arch. Biochem. Biophys."},{"key":"23431_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-016-0393-1","author":"CC Adarkwah","year":"2016","unstructured":"Adarkwah, C. C. et al. Time-to-event versus ten-year-absolute-risk in cardiovascular risk prevention\u2014Does it make a difference? Results from the Optimizing-Risk-Communication (OptRisk) randomized-controlled trial. BMC Med. Inf. Decis. Mak. https:\/\/doi.org\/10.1186\/s12911-016-0393-1 (2016).","journal-title":"BMC Med. Inf. Decis. Mak."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23431-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:23:47Z","timestamp":1760541827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23431-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23431"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23431-y","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.compbiomed.2024.109245","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors consented to the publication of this work. All authors confirm the permission to publish this research work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"36114"}}